One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2

✍ Scribed by Sandborn, W. J.; Colombel, J.-F.; D'Haens, G.; Van Assche, G.; Wolf, D.; Kron, M.; Lazar, A.; Robinson, A. M.; Yang, M.; Chao, J. D.; Thakkar, R.

• Book ID: 119826710
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 386 KB
• Volume: 37
• Category: Article
• ISSN: 0269-2813
• DOI: 10.1111/apt.12145